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The novel SARS-CoV-2 (COVID-19) became a pan-
demic on 11 March 2020. The epidemiological picture is
constantly evolving, and on 13 May, 4,170,424 cases and
287,399 confirmed deaths have been reported (WHO Re-
port). People with COVID-19 infection may show several
symptoms, including fever, cough, nausea, vomiting, dys-
pnea, myalgia, fatigue, arthralgia, headache, diarrhea, and
rarely arthritis [1]. COVID-19 clinical features range from
asymptomatic patients to acute respiratory distress syn-
drome (ARDS) and multiple organ dysfunction [2, 3]. In-
fluenza symptoms are associated with a cascade of
inflammatory mediators. Interleukin-6 (IL-6) and tumor
necrosis factor-α (TNF- α) levels in plasma and upper re-
spiratory secretions directly correlate with the magnitude
of viral replication, fever, and respiratory and systemic
symptoms, including musculoskeletal clinical manifesta-
tions [4, 5] Musculoskeletal symptoms such as fatigue,
myalgia and arthralgia are common COVID-19 symp-
toms, but their prevalence has not yet been systematically
investigated [6, 7]. We collected the published clinical data
of the past 5 months to ascertain the prevalence of muscu-
loskeletal symptoms and epidemiological characteristics
published worldwide in COVID-19 patients.
Data were tabulated using Microsoft ExcelTM 2020
V.16.34. The value was showed as mean ± SD. Student t
test was used to reveal musculoskeletal symptoms be-
tween the total sample. To assess the incidence for each
clinical variable, frequency analysis was performed. Re-
gression analysis (R2) was used to examine correlations
between the total sample and musculoskeletal symptoms
extracted. The level of significant was set at p < 0.05.
The relevant reference and the data collected from the
included articles are indicated in Tables 1 and 2.
Data on 12,046 patients (54% male and 46% females)
were available. The number of patients in the selected stud-
ies ranged from 5 to 1590 patients (223 ± 312 patients).
The sex ratio (male to female) was 1:15, and the overall
average of patients was 52.13 years. The majority of the
studies arose from China, mainly from Wuhan; one was
from Singapore [57], two from Europe [46, 59], one from
the USA [36], and one from Bolivia [58]. Musculoskeletal
symptoms were present from the earliest stage of the viral
illness and were reported in patients necessitating intensive
care in the end stage of the condition. The total prevalence
of fatigue symptom was 25.6% (R2 =0.56; p value = 0.004),
while the prevalence of arthralgia and/or myalgia was 15.5%
(R2 = 0.66; p value = 0.001; Fig. 1).
Eight studies reported a prevalence higher than 50% of
patients with fatigue [8, 9, 24, 25, 28, 37, 46, 47], while
three studies reported higher values for arthralgia/myal-
gia symptoms [50, 53, 59]. The prevalence of musculo-
skeletal symptoms in studies from Europe reached high
values [46, 59]; Lechien et al., for example, reported on
417 COVID-19 patients from 12 European hospitals and
found myalgia in 246 (59%) and arthralgia in 129 (31%)
of these patients [59].
Clinical presentation of COVID-19 ranges from ab-
sence of symptoms to severe pneumonia. Fever, dry
cough and fatigue are common symptoms, as indeed are
myalgia and arthralgia [6, 53]. Most of the articles are
retrospective single center studies: data were collected in
a non-homogeneous way, especially regarding comorbid-
ities, lifestyle habits, and severity of the illness. Based on
our work, we cannot state, for example, whether chil-
dren and younger patients less commonly present mus-
culoskeletal symptoms at onset [63]. Most studies
originate from China, which is not surprising, and it is
not clear whether the prevalence of musculoskeletal
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Table 1 Demographics
Study (year) No. of patients Sex Age
(mean SD or median IQR)
Study design Country
Zheng et al. [8] 99 M 51
F 48
49.40 (SD 18.45) Retrospective single center China
Lei et al. [9] 34 M 14
F 20
55 (43–63) Retrospective single center China
Mo et al. [10] 155 M 86
F 69
54 (42–66) Retrospective single center China
Qian et al. [11] 91 M 37
F 54
50 (54–80) Retrospective multi-center China
Ma et al. [12] 37 M 20
F 17
62 (59–70) Retrospective single center China
Jin et al. [13] 651 M 331
F 246
46.0 (32–60) Retrospective multi-center China
Zheng et al. [14] 161 M 80
F 81
45.0 (33.5–57) Retrospective single center China
Wang et al. [15] 80 M 31
F 49
39.0 (32–48.5) Retrospective multi-center (electronic database) China
Chen et al. [16] 203 M 108
F 95
54.0 (20–91) Retrospective single center China
Zhou et al. [17] 21 M 13
F 8
66.1 (SD 13.94) Retrospective single center China
Lo et al. [18] 10 M 3
F 7
54 (27–64) Retrospective single center China
Huang et al. [19] 41 M 30
F 11
49.0 (41.0–58.0) Prospective multi-center (electronic database) China
Zhang et al. [20] 645 M 328
F 317
46.65 (SD 13.82) Retrospective multi-center (electronic database) China
Chen et al. [21] 249 M 126
F 123
51.0 (36–64) Retrospective single center China
Feng et al. [22] 476 M 271
F 205
53.0 (40–64) Retrospective multi-center China
Chen et al. [23] 274 M 171
F 103
62.0 (44–70) Retrospective single center China
Zhang et al. [24] 140 M 71
F 69
57.0 (25–87) Retrospective multi-center China
Lian et al. [25] 788 M 407
F 381
41.15 (SD 11.38) Retrospective multi-center (electronic database) China
Cai et al. [26] 298 M 145
F 153
47.5 (33–61) Retrospective single center China
Wan et al. [27] 135 M 72
F 63
47.0 (36–55) Retrospective single center China
Cao et al. [28] 102 M 53
F 49
54.0 (37–67) Retrospective single center China
Wang et al. [29] 339 M 166
F 173
69.0 (65–76) Retrospective single center China
Xu et al. [30] 62 M 36
F 27
41.0 (32–52) Retrospective single center China
Zhou et al. [31] 191 M 119
F 72
56.0 (46–67) Retrospective multi-center cohort study China
Wu et al. [32] 201 M 128
F 73
51.0 (43–60) Retrospective single center cohort study China
Du et al. [33] 85 M 62
F 23
65.8 Retrospective multi-center China
Wang et al. [34] 69 M 32
F 37
42.0 (35–62) Retrospective single center China
Guan et al. [35] 1099 M 640 47.0 (35–58) Retrospective multi-center China
Cipollaro et al. Journal of Orthopaedic Surgery and Research          (2020) 15:178 Page 2 of 7
Table 1 Demographics (Continued)
Study (year) No. of patients Sex Age
(mean SD or median IQR)
Study design Country
F 459
Goyal et al. [36] 393 M 238
F 155
62.2 (49–74) Retrospective multi-center USA
Zhang et al. [37] 28 M 17
F 11
65.0 (56–70) Retrospective single center China
Chen et al. [38] 118 M 0
F 118
31.0 (28–34) Retrospective single center China
Wang et al. [39] 1012 M 524
F 488
50.0 (39–58) Retrospective multi-center China
Xia et al. [40] 10 M 6
F 4
56.5 Retrospective single center China
Liang et al. [41] 1590 M 904
F 674
48.9 (SD 16.3) Retrospective multi-center China
Dai et al. [42] 234 M 136
F 98
44.6 Retrospective single center China
Li et al. [43] 25 M 12
F 13
45.6 Retrospective single center China
Chu et al. [44] 54 M 36
F 18
39 Retrospective single center China
Qi et al. [45] 70 M 39
F 31
39.5 Retrospective multi-center China
Godaert et al. [46] 17 M 8
F 9
86.5 Retrospective single center France
Ye et al. [47] 5 M 2
F 3
30.0 Retrospective single center China
Huang et al. [48] 22 M 6
F 16
22.0 (16.0–23.0) Retrospective single center China
Tian et al. [49] 262 M 127
F 135
47.5 Retrospective single center China
Huang et al. [50] 34 M 14
F 20
56.2 Retrospective single center China
Xia et al. [51] 20 M 13
F 7
1.5 Retrospective single center China
Zhao et al. [52] 101 M 56
F 45
44.44 Retrospective multi-center China
Xu et al. [53] 51 M 25
F 26
41.6 Retrospective single center China
Li et al. [54] 548 M 279
F 269
60.0 (48–69) Retrospective single center China
Xu et al. [55] 90 M 39
F 51
50.0 (18–86) Retrospective single center China
Lei et al. [56] 119 M 77
F 42
49.0 (SD 13.6) Retrospective multi-center China
Pung et al. [57] 17 M 7
F 10
40.0 Retrospective single center Singapore
Xu et al. [71] 50 M 29
F 21
42.3 Retrospective single center China
Escalera-Antezana et al. [58] 12 M 6
F 6
36.5 Retrospective single center Bolivia
Lechien et al. [59] 417 M 154
F 263
36.9 (SD 11.4) Retrospective multi-center Europe
Dong et al. [72] 11 M 5
F 6
40.3 Retrospective single center China
Total: 54 12.046 M 6427 (54%)
F 5597 (46%)
52.13
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Table 2 Musculoskeletal symptoms
Study (year) No. of patients Fatigue (nr/%) Arthralgia/Myalgia (nr/%)
Zheng et al. [37] 99 72 (73%) 12 (12%)
Lei et al. [36] 34 25 (73.5%) 11 (32.4%)
Mo et al. [60] 155 60 (73.2) 50 (61.0%)
Qian et al. [61] 91 40 (43.96%) 5 (5.49%)
Ma et al. [62] 37 4 (10.8%) 4 (10.8%)
Jin et al. [10] 651 119 (18.2%) /
Zheng et al. [11] 161 64 (39.8%) 18 (11.2%)
Wang et al. [12] 80 28 (35%) 19 (23.75%)
Chen et al. [13] 203 16 (7.9%) 54 (26.6)
Zhou et al. [14] 21 5 (23.8%) 2 (9.5%)
Lo et al. [15] 10 / 3 (30%)
Huang et al. [16] 41 18 (44%) /
Zhang et al. [17] 645 118 (18.3%) 71 (11%)
Chen et al. [18] 249 39 (15.7%) /
Feng et al. [19] 476 / 59 (12.4%)
Chen et al. [20] 274 137 (50%) 60 (22%)
Zhang et al. [58] 140 105 (75%) /
Lian et al. [47] 788 139 (17.6%) 91 (11.5%)
Cai et al. [21] 298 13 (4.3%) /
Wan et al. [22] 135 / 44 (32.5%)
Cao et al. [9] 102 56 (54.9%) 35 (34.3)
Wang et al. [32] 339 135 (39.9%) 16 (4.7%)
Xu et al. [26] 62 / 32 (52%)
Zhou et al. [27] 191 44 (23%) 29 (15%)
Wu et al. [29] 201 65 (32.3%) /
Du et al. [33] 85 50 (58.8%) 14 (16.5%)
Wang et al. [35] 69 29 (42%) 21 (30%)
Guan et al. [33] 1099 419 (38%) 164 (15%)
Goyal et al. [46] 393 / 94 (24%)
Zhang et al. [24] 28 18 (64%) 4 (14%)
Chen et al. [34] 118 19 (16%) /
Wang et al. [41] 1012 / 170 (17%)
Xia et al. [38] 10 3 (30%) /
Liang et al. [39] 1590 680 (43%) 278 (17%)
Dai et al. [40] 234 31 (13%) 21 (9%)
Li et al. [41] 25 17 (68%) /
Chu et al. [42] 54 9 (17%) 3 (6%)
Qi et al. [43] 70 / 12 (17%)
Godaert et al. [7] 17 10 (59%) /
Ye et al. [28] 5 5 (100%) /
Huang et al. [44] 22 5 (23%) 4 (18%)
Tian et al. [45] 262 69 (26%) /
Huang et al. [8] 34 / 22 (65%)
Xia et al. [48] 20 1 (5%) /
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symptoms at onset is influenced by socio-geographical
factors [64]. The most common symptoms in patients
with mild to moderate clinical presentation of the condi-
tion are fever, fatigue, and dry cough, followed by other
symptoms including headache, nasal congestion, sore
throat, myalgia, and arthralgia [65, 66].
The evidence on the central role of inflammation
during COVID-19 infection underlines the need to
block this inflammatory cascade [30, 60–62, 67–70].
The presence of musculoskeletal symptoms is worry-
ing: there is a high rate of use, especially in the mid-
dle age and elderly population, of NSAIDs. The fact
that patients therefore report musculoskeletal symp-
toms is even more worrying because it may imply
that the inflammatory reactions overcome the anti-
inflammatory effect of such drugs.
Clinical features have to be analyzed deeply, espe-
cially considering the new evidences on COVID-19.
Musculoskeletal symptoms should be married with la-
boratory findings, such as inflammatory and infection-
related parameters (Interleukin-6, Procalcitonin, C-
reactive protein). Understandably, the involvement of
the musculoskeletal system has not been deeply inves-
tigated during this pandemic, but synovial and muscle
biopsy, and joint fluid analysis, for example, should
clarify how extensive the attack of the virus on the
whole of the human body is. Until now, no report
has been published on the presence of COVID-19 in
the skeletal muscles, joint, or bones. The musculo-
skeletal symptoms are only anecdotally attributed to
indirect effects, mainly arising from inflammatory
and/or immune response, but other mechanisms can
Table 2 Musculoskeletal symptoms (Continued)
Study (year) No. of patients Fatigue (nr/%) Arthralgia/Myalgia (nr/%)
Zhao et al. [49] 101 / 17 (17%)
Xu et al. [25] 51 2 (4%) 8 (16%)
Li et al. [51] 548 258 (47%) 111 (20%)
Xu et al. [52] 90 19 (21%) 25 (28%)
Lei et al. [54] 119 / 18 (15%)
Pung et al. [6] 17 / 5 (29%)
Xu et al. [55] 50 8 (16%) 8 (16%)
Escalera-Antezana et al. [59] 12 / 5 (42%)
Lechien et al. [57] 417 129 (31%) 246 (59%)
Dong et al. [56] 11 2 (18%) 1 (9%)
Total: 54 Tot: 12,046 3085 (25.6%) 1866 (15.5%)
Fig. 1 Relationships of fatigue and arthralgia/myalgia on all patients
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be hypothesized, such as direct damage by the virus
on the endothelium or peripheral nerves. These
findings could help to plan specific rehabilitation
protocols in COVID-19 patients.
As a new infectious disease, it is particularly important
to underline the clinical features of COVID-19, espe-
cially in the early stage of the illness, to help clinicians
to individuate and isolate patients earlier, and then
minimize its diffusion. From the onset of the symptoms
and to the most severe stages of COVID-19 disease,
musculoskeletal symptoms, including myalgia, arthralgia,
and fatigue, are a nearly constant presence. It is still un-
clear how the effects of COVID-19 on the musculoskel-
etal system are mediated.
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